Literature DB >> 24519860

Drug-eluting stent or coronary artery bypass graft surgery in hemodialysis patients?

Flavio Ribichini1, Corrado Vassanelli.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24519860     DOI： 10.1007/s40620-013-0010-7

Source DB:  PubMed          Journal:  J Nephrol        ISSN： 1121-8428            Impact factor:   3.902


× No keyword cloud information.
  8 in total

1.  Guidelines on myocardial revascularization.

Authors:  William Wijns; Philippe Kolh; Nicolas Danchin; Carlo Di Mario; Volkmar Falk; Thierry Folliguet; Scot Garg; Kurt Huber; Stefan James; Juhani Knuuti; Jose Lopez-Sendon; Jean Marco; Lorenzo Menicanti; Miodrag Ostojic; Massimo F Piepoli; Charles Pirlet; Jose L Pomar; Nicolaus Reifart; Flavio L Ribichini; Martin J Schalij; Paul Sergeant; Patrick W Serruys; Sigmund Silber; Miguel Sousa Uva; David Taggart
Journal:  Eur Heart J       Date:  2010-08-29       Impact factor: 29.983

2.  Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease.

Authors:  Guha Ashrith; Vei-Vei Lee; Macarthur A Elayda; Ross M Reul; James M Wilson
Journal:  Am J Cardiol       Date:  2010-06-18       Impact factor: 2.778

3.  Propensity-matched comparison of drug-eluting stent implantation and coronary artery bypass graft surgery in chronic hemodialysis patients.

Authors:  Chung Hee Baek; Seon-Ok Kim; Seung-Jung Park; Jae Won Lee; Soon Bae Kim; Kyung Min Kim
Journal:  J Nephrol       Date:  2013-12-13       Impact factor: 3.902

4.  A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).

Authors:  Flavio Ribichini; Michele Romano; Renato Rosiello; Luigi La Vecchia; Ester Cabianca; Giuseppe Caramanno; Diego Milazzo; Paolo Loschiavo; Stefano Rigattieri; Salvatore Musarò; Bruno Pironi; Antonio Fiscella; Francesco Amico; Ciro Indolfi; Carmen Spaccarotella; Antonio Bartorelli; Daniela Trabattoni; Francesco Della Rovere; Andrea Rolandi; Federico Beqaraj; Riccardo Belli; Pietro Sangiorgio; Rosvaldo Villani; Andrea Berni; Imad Sheiban; Maria Josè Lopera Quijada; Barbara Cappi; Licia Ribaldi; Corrado Vassanelli
Journal:  JACC Cardiovasc Interv       Date:  2013-09-18       Impact factor: 11.195

5.  The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease.

Authors:  D Charytan; R E Kuntz
Journal:  Kidney Int       Date:  2006-10-18       Impact factor: 10.612

6.  Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.

Authors:  Nagesh S Anavekar; John J V McMurray; Eric J Velazquez; Scott D Solomon; Lars Kober; Jean-Lucien Rouleau; Harvey D White; Rolf Nordlander; Aldo Maggioni; Kenneth Dickstein; Steven Zelenkofske; Jeffrey D Leimberger; Robert M Califf; Marc A Pfeffer
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

7.  Rationale and design of the Randomized comparison of XiEnce V and Multilink VisioN coronary stents in the sAme muLtivessel patient with chronic kiDnEy disease (RENAL-DES) study.

Authors:  Fabrizio Tomai; Alessandro Petrolini; Leonardo De Luca; Francesco Nudi; Gaetano Lanza; Corrado Vassanelli; Flavio Ribichini
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2010-04       Impact factor: 2.160

Review 8.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690
  8 in total
  1 in total

Review 1.  How to balance risks and benefits in the management of CKD patients with coronary artery disease.

Authors:  Giancarlo Marenzi; Nicola Cosentino; Carlo Guastoni
Journal:  J Nephrol       Date:  2015-02-25       Impact factor: 3.902
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.